- Home
- Publications
- Publication Search
- Publication Details
Title
Neurological Complications of HIV Infection
Authors
Keywords
HIV, HIV-associated neurocognitive disorder, Immune activation, CNS escape
Journal
Current Infectious Disease Reports
Volume 19, Issue 12, Pages -
Publisher
Springer Nature
Online
2017-11-21
DOI
10.1007/s11908-017-0606-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High Number of Activated CD8+ T Cells Targeting HIV Antigens Are Present in Cerebrospinal Fluid in Acute HIV Infection
- (2017) Cari F. Kessing et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- HIV persistence in tissue macrophages of humanized myeloid-only mice during antiretroviral therapy
- (2017) Jenna B Honeycutt et al. NATURE MEDICINE
- Maraviroc-intensified combined antiretroviral therapy improves cognition in virally suppressed HIV-associated neurocognitive disorder
- (2016) Thomas M. Gates et al. AIDS
- Rates of non-confounded HIV-associated neurocognitive disorders in men initiating combination antiretroviral therapy during primary infection
- (2016) Teresa H. Evering et al. AIDS
- Macrophages sustain HIV replication in vivo independently of T cells
- (2016) Jenna B. Honeycutt et al. JOURNAL OF CLINICAL INVESTIGATION
- HIV DNA Is Frequently Present within Pathologic Tissues Evaluated at Autopsy from Combined Antiretroviral Therapy-Treated Patients with Undetectable Viral Loads
- (2016) Susanna L. Lamers et al. JOURNAL OF VIROLOGY
- Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study
- (2016) Magnus Gisslén et al. EBioMedicine
- APOE ε4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals – a cross-sectional observational study
- (2015) Lucette A Cysique et al. BMC Neurology
- The CCL2/CCR2 Axis in the Pathogenesis of HIV-1 Infection: A New Cellular Target for Therapy?
- (2015) Daniela Angela Covino et al. CURRENT DRUG TARGETS
- Neuropsychological Impairment in Acute HIV and the Effect of Immediate Antiretroviral Therapy
- (2015) Idil Kore et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Blood brain barrier impairment is associated with cerebrospinal fluid markers of neuronal damage in HIV-positive patients
- (2015) A. Calcagno et al. JOURNAL OF NEUROVIROLOGY
- Compartmentalized Replication of R5 T Cell-Tropic HIV-1 in the Central Nervous System Early in the Course of Infection
- (2015) Christa Buckheit Sturdevant et al. PLoS Pathogens
- Blood-brain barrier dysfunction in disorders of the developing brain
- (2015) Raffaella Moretti et al. Frontiers in Neuroscience
- Neurological Response to cART vs. cART plus Integrase Inhibitor and CCR5 Antagonist Initiated during Acute HIV
- (2015) Victor G. Valcour et al. PLoS One
- Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activation
- (2014) Viktor Dahl et al. AIDS
- Short Communication: Focal Encephalitis Related to Viral Escape and Resistance Emergence in Cerebrospinal Fluid in a Patient on Lopinavir/Ritonavir Monotherapy with Plasma HIV-1 RNA Suppression
- (2014) Arkaitz Imaz et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Comparison of Risk and Age at Diagnosis of Myocardial Infarction, End-Stage Renal Disease, and Non-AIDS-Defining Cancer in HIV-Infected Versus Uninfected Adults
- (2014) Keri N. Althoff et al. CLINICAL INFECTIOUS DISEASES
- Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline
- (2014) I. Grant et al. NEUROLOGY
- CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival
- (2014) T. Skillback et al. NEUROLOGY
- White Matter Signal Abnormalities in Children With Suspected HIV-related Neurologic Disease on Early Combination Antiretroviral Therapy
- (2014) Christelle Ackermann et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Cerebrospinal Fluid (CSF) Neuronal Biomarkers across the Spectrum of HIV Infection: Hierarchy of Injury and Detection
- (2014) Julia Peterson et al. PLoS One
- Central Nervous System HIV Infection in “Less-Drug Regimen” Antiretroviral Therapy Simplification Strategies
- (2014) Nicola Gianotti et al. SEMINARS IN NEUROLOGY
- Update on the key developments of the neurologic complications in children infected with HIV
- (2014) Jo M. Wilmshurst et al. Current Opinion in HIV and AIDS
- Anti-α4 Antibody Treatment Blocks Virus Traffic to the Brain and Gut Early, and Stabilizes CNS Injury Late in Infection
- (2014) Jennifer H. Campbell et al. PLoS Pathogens
- Adverse events associated with nevirapine and efavirenz-based first-line antiretroviral therapy
- (2013) Zara Shubber et al. AIDS
- Randomized Trial of Central Nervous System–Targeted Antiretrovirals for HIV-Associated Neurocognitive Disorder
- (2013) Ronald J. Ellis et al. CLINICAL INFECTIOUS DISEASES
- Neurological and psychiatric tolerability of rilpivirine (TMC278)vs.efavirenz in treatment-naïve, HIV-1-infected patients at 48 weeks
- (2013) AM Mills et al. HIV MEDICINE
- Cerebrospinal fluid neopterin decay characteristics after initiation of antiretroviral therapy
- (2013) Aylin Yilmaz et al. Journal of Neuroinflammation
- Cellular Composition of Cerebrospinal Fluid in HIV-1 Infected and Uninfected Subjects
- (2013) Emily L. Ho et al. PLoS One
- Discontinuation of efavirenz therapy in HIV patients due to neuropsychiatric adverse effects
- (2013) Peter Derek Christian Leutscher et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load
- (2012) Michael J. Peluso et al. AIDS
- Improved Neuropsychological and Neurological Functioning Across Three Antiretroviral Regimens in Diverse Resource-Limited Settings: AIDS Clinical Trials Group Study A5199, the International Neurological Study
- (2012) K. Robertson et al. CLINICAL INFECTIOUS DISEASES
- Central Nervous System Viral Invasion and Inflammation During Acute HIV Infection
- (2012) Victor Valcour et al. JOURNAL OF INFECTIOUS DISEASES
- A diffusion tensor imaging and neurocognitive study of HIV-positive children who are HAART-naïve “slow progressors”
- (2012) Jacqueline Hoare et al. JOURNAL OF NEUROVIROLOGY
- Impact of HIV Severity on Cognitive and Adaptive Functioning During Childhood and Adolescence
- (2012) Renee Smith et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Change in Brain Magnetic Resonance Spectroscopy after Treatment during Acute HIV Infection
- (2012) Napapon Sailasuta et al. PLoS One
- Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment
- (2011) Jarek Harezlak et al. AIDS
- Premature Age-Related Comorbidities Among HIV-Infected Persons Compared With the General Population
- (2011) G. Guaraldi et al. CLINICAL INFECTIOUS DISEASES
- HIV-1 infection and cognitive impairment in the cART era: a review
- (2010) Judith Schouten et al. AIDS
- Incidence and Impact on Mortality of Severe Neurocognitive Disorders in Persons With and Without HIV Infection: A Danish Nationwide Cohort Study
- (2010) F.-X. Lescure et al. CLINICAL INFECTIOUS DISEASES
- HIV‐1 Viral Escape in Cerebrospinal Fluid of Subjects on Suppressive Antiretroviral Treatment
- (2010) Arvid Edén et al. JOURNAL OF INFECTIOUS DISEASES
- HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors
- (2010) Robert K. Heaton et al. JOURNAL OF NEUROVIROLOGY
- Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance
- (2009) Christina M Marra et al. AIDS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started